1 Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Hu Y, Liu H, Zheng C, Li P, Xie J, Liu F, Li Z, Zhao G, Yang K, Liu C, Li H, Chen P, Ji J, Li G. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. Jama 2019; 321(20): 1983-1992 [PMID: 31135850 PMCID: PMC6547120 DOI: 10.1001/jama.2019.5359]
2 Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J, Xue Y, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Chen P, Liu H, Zheng C, Liu F, Yu J, Li Z, Zhao G, Chen X, Wang K, Li P, Xing J, Li G. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; 34(12): 1350-1357 [PMID: 26903580 DOI: 10.1200/jco.2015.63.7215]
3 Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer letters 2017; 387: 95-105 [PMID: 27037062 DOI: 10.1016/j.canlet.2016.03.042]
4 Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014; 24(10): R453-R462 [PMID: 24845678 DOI: 10.1016/j.cub.2014.03.034]
5 Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002; 54(1): 101-127 [PMID: 11870261 DOI: 10.1124/pr.54.1.101]
6 Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 2008; 18(4): 165-173 [PMID: 18296052 DOI: 10.1016/j.tcb.2008.01.006]
7 Jin T, Wang C, Tian Y, Dai C, Zhu Y, Xu F. Mitochondrial metabolic reprogramming: An important player in liver cancer progression. Cancer letters 2020; 470: 197-203 [PMID: 31783085 DOI: 10.1016/j.canlet.2019.11.029]
8 Zong W-X, Rabinowitz JD, White E. Mitochondria and Cancer. Molecular cell 2016; 61(5): 667-676 [PMID: 26942671 DOI: 10.1016/j.molcel.2016.02.011]
9 Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer & metabolism 2015; 3(1): 1-1 [PMID: 25621173 DOI: 10.1186/s40170-015-0128-2]
10 Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip A-NA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, Chang E, Ciurea S, Cross JB, Czako B, Deem A, Daver N, de Groot JF, Dong J-W, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T, Konoplev S, Lin Y-H, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q, Muller F, DePinho RA, Toniatti C, Draetta GF, Heffernan TP, Konopleva M, Jones P, Di Francesco ME, Marszalek JR. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nature medicine 2018; 24(7): 1036-1046 [PMID: 29892070 DOI: 10.1038/s41591-018-0052-4]
11 Cadenas S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg 2018; 1859(9): 940-950 [PMID: 29859845 DOI: 10.1016/j.bbabio.2018.05.019]
12 Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nature medicine 2016; 22(2): 146-153 [PMID: 26779811 DOI: 10.1038/nm.4027]
13 Chang M, Wang M, Shu M, Zhao Y, Ding B, Huang S, Hou Z, Han G, Lin J. Enhanced photoconversion performance of NdVO(4)/Au nanocrystals for photothermal/photoacoustic imaging guided and near infrared light-triggered anticancer phototherapy. Acta biomaterialia 2019; 99: 295-306 [PMID: 31437636 DOI: 10.1016/j.actbio.2019.08.026]
14 Chang Y, Feng Y, Cheng Y, Zheng R, Wu X, Jian H, Zhang D, Tang Z, Wang Z, Hao J, Zhang H. Anisotropic Plasmonic Metal Heterostructures as Theranostic Nanosystems for Near Infrared Light-Activated Fluorescence Amplification and Phototherapy. Adv Sci (Weinh) 2019; 6(11): 1900158-1900158 [PMID: 31179221 DOI: 10.1002/advs.201900158]
15 Song Y, Shi Q, Zhu C, Luo Y, Lu Q, Li H, Ye R, Du D, Lin Y. Mitochondrial-targeted multifunctional mesoporous Au@Pt nanoparticles for dual-mode photodynamic and photothermal therapy of cancers. Nanoscale 2017; 9(41): 15813-15824 [PMID: 29018855 DOI: 10.1039/c7nr04881e]
16 Yang Z, Wang J, Liu S, Li X, Miao L, Yang B, Zhang C, He J, Ai S, Guan W. Defeating relapsed and refractory malignancies through a nano-enabled mitochondria-mediated respiratory inhibition and damage pathway. Biomaterials 2020; 229: 119580-119580 [PMID: 31707296 DOI: 10.1016/j.biomaterials.2019.119580]
17 Zhou Z, Song J, Nie L, Chen X. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev 2016; 45(23): 6597-6626 [PMID: 27722328 DOI: 10.1039/c6cs00271d]
18 Oei AL, Kok HP, Oei SB, Horsman MR, Stalpers LJA, Franken NAP, Crezee J. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Advanced drug delivery reviews 2020: S0169-0409X(0120)30005-30003 [PMID: 31982475 DOI: 10.1016/j.addr.2020.01.003]
19 Peng C, Liang Y, Chen Y, Qian X, Luo W, Chen S, Zhang S, Dan Q, Zhang L, Li M, Yuan M, Zhao B, Li Y. Hollow Mesoporous Tantalum Oxide Based Nanospheres for Triple Sensitization of Radiotherapy. ACS applied materials & interfaces 2020; 12(5): 5520-5530 [PMID: 31891473 DOI: 10.1021/acsami.9b20053]
20 Wu J, Bremner DH, Niu S, Shi M, Wang H, Tang R, Zhu LM. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer. ACS applied materials & interfaces 2018; 10(49): 42115-42126 [PMID: 30462492 DOI: 10.1021/acsami.8b16448]
21 Lu N, Fan W, Yi X, Wang S, Wang Z, Tian R, Jacobson O, Liu Y, Yung BC, Zhang G, Teng Z, Yang K, Zhang M, Niu G, Lu G, Chen X. Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy. ACS nano 2018; 12(2): 1580-1591 [PMID: 29384652 DOI: 10.1021/acsnano.7b08103]
22 Gu X, Qiu Y, Lin M, Cui K, Chen G, Chen Y, Fan C, Zhang Y, Xu L, Chen H, Wan JB, Lu W, Xiao Z. CuS Nanoparticles as a Photodynamic Nanoswitch for Abrogating Bypass Signaling To Overcome Gefitinib Resistance. Nano letters 2019; 19(5): 3344-3352 [PMID: 30974946 DOI: 10.1021/acs.nanolett.9b01065]
23 Chen W-H, Luo G-F, Lei Q, Hong S, Qiu W-X, Liu L-H, Cheng S-X, Zhang X-Z. Overcoming the Heat Endurance of Tumor Cells by Interfering with the Anaerobic Glycolysis Metabolism for Improved Photothermal Therapy. ACS nano 2017; 11(2): 1419-1431 [PMID: 28107631 DOI: 10.1021/acsnano.6b06658]
24 Yoo D, Jeong H, Noh S-H, Lee J-H, Cheon J. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. Angewandte Chemie (International ed in English) 2013; 52(49): 13047-13051 [PMID: 24281889 DOI: 10.1002/anie.201306557]
25 Xing X, Zhang B, Wang X, Liu F, Shi D, Cheng Y. An "imaging-biopsy" strategy for colorectal tumor reconfirmation by multipurpose paramagnetic quantum dots. Biomaterials 2015; 48: 16-25 [PMID: 25701028 DOI: 10.1016/j.biomaterials.2015.01.011]
26 Yu J, Diao X, Zhang X, Chen X, Hao X, Li W, Zhang X, Lee C-S. Water-dispersible, pH-stable and highly-luminescent organic dye nanoparticles with amplified emissions for in vitro and in vivo bioimaging. Small (Weinheim an der Bergstrasse, Germany) 2014; 10(6): 1125-1132 [PMID: 24318966 DOI: 10.1002/smll.201302230]
27 Wang Z, Zhang F, Shao D, Chang Z, Wang L, Hu H, Zheng X, Li X, Chen F, Tu Z, Li M, Sun W, Chen L, Dong W-F. Janus Nanobullets Combine Photodynamic Therapy and Magnetic Hyperthermia to Potentiate Synergetic Anti-Metastatic Immunotherapy. Adv Sci (Weinh) 2019; 6(22): 1901690-1901690 [PMID: 31763151 DOI: 10.1002/advs.201901690]
28 Zhang X, Xi Z, Machuki JOa, Luo J, Yang D, Li J, Cai W, Yang Y, Zhang L, Tian J, Guo K, Yu Y, Gao F. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging. ACS nano 2019; 13(5): 5306-5325 [PMID: 31018094 DOI: 10.1021/acsnano.8b09786]
29 Wang FH, Bae K, Huang ZW, Xue JM. Two-photon graphene quantum dot modified Gd(2)O(3) nanocomposites as a dual-mode MRI contrast agent and cell labelling agent. Nanoscale 2018; 10(12): 5642-5649 [PMID: 29528344 DOI: 10.1039/c7nr08068a]
30 Shen Z, Fan W, Yang Z, Liu Y, Bregadze VI, Mandal SK, Yung BC, Lin L, Liu T, Tang W, Shan L, Liu Y, Zhu S, Wang S, Yang W, Bryant LH, Nguyen DT, Wu A, Chen X. Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors. Small (Weinheim an der Bergstrasse, Germany) 2019; 15(41): e1903422-e1903422 [PMID: 31448577 DOI: 10.1002/smll.201903422]
31 Chen W, Wang X, Zhao B, Zhang R, Xie Z, He Y, Chen A, Xie X, Yao K, Zhong M, Yuan M. CuS-MnS(2) nano-flowers for magnetic resonance imaging guided photothermal/photodynamic therapy of ovarian cancer through necroptosis. Nanoscale 2019; 11(27): 12983-12989 [PMID: 31264665 DOI: 10.1039/c9nr03114f]
32 You Q, Sun Q, Wang J, Tan X, Pang X, Liu L, Yu M, Tan F, Li N. A single-light triggered and dual-imaging guided multifunctional platform for combined photothermal and photodynamic therapy based on TD-controlled and ICG-loaded CuS@mSiO(2). Nanoscale 2017; 9(11): 3784-3796 [PMID: 28067380 DOI: 10.1039/c6nr09042g]
33 Li W, Peng J, Tan L, Wu J, Shi K, Qu Y, Wei X, Qian Z. Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles. Biomaterials 2016; 106: 119-133 [PMID: 27561883 DOI: 10.1016/j.biomaterials.2016.08.016]
34 Jin R-M, Yang J, Ding P, Li C, Zhang B, Chen W, Zhao Y-D, Cao Y, Liu B. Antitumor Immunity triggered by photothermal therapy and photodynamic therapy of a 2D MoS2 nanosheet-incorporated injectable polypeptide-engineered hydrogel combinated with chemotherapy for 4T1 breast tumor therapy. Nanotechnology 2020: 10.1088/1361-6528/ab1072b1089 [PMID: 32018232 DOI: 10.1088/1361-6528/ab72b9]
35 Bradford JA, Clarke ST. Dual-pulse labeling using 5-ethynyl-2'-deoxyuridine (EdU) and 5-bromo-2'-deoxyuridine (BrdU) in flow cytometry. Curr Protoc Cytom 2011; Chapter 7: 7.38 [PMID: 21207361 DOI: 10.1002/0471142956.cy0738s55]
36 Hu Y, Huang L, Shen M, Liu Y, Liu G, Wu Y, Ding F, Ma K, Wang W, Zhang Y, Shao Z, Cai X, Xiong L. Pioglitazone Protects Compression-Mediated Apoptosis in Nucleus Pulposus Mesenchymal Stem Cells by Suppressing Oxidative Stress. Oxid Med Cell Longev 2019; 2019: 4764071-4764071 [PMID: 31885796 DOI: 10.1155/2019/4764071]
37 Bhandary B, Marahatta A, Kim HR, Chae HJ. An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. International journal of molecular sciences 2012; 14(1): 434-456 [PMID: 23263672 PMCID: PMC3565273 DOI: 10.3390/ijms14010434]
38 Loreto C, La Rocca G, Anzalone R, Caltabiano R, Vespasiani G, Castorina S, Ralph DJ, Cellek S, Musumeci G, Giunta S, Djinovic R, Basic D, Sansalone S. The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease. BioMed research international 2014; 2014: 616149 [PMID: 25197653 PMCID: PMC4147380 DOI: 10.1155/2014/616149]
39 Zhang W, Hu X, Shen Q, Xing D. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Nature communications 2019; 10(1): 1704-1704 [PMID: 30979885 DOI: 10.1038/s41467-019-09566-3]
40 Deng L, Guo W, Li G, Hu Y, Zhang L-M. Hydrophobic IR780 loaded sericin nanomicelles for phototherapy with enhanced antitumor efficiency. International journal of pharmaceutics 2019; 566: 549-556 [PMID: 31158452 DOI: 10.1016/j.ijpharm.2019.05.075]
41 Oparka M, Walczak J, Malinska D, van Oppen LMPE, Szczepanowska J, Koopman WJH, Wieckowski MR. Quantifying ROS levels using CM-H(2)DCFDA and HyPer. Methods (San Diego, Calif) 2016; 109: 3-11 [PMID: 27302663 DOI: 10.1016/j.ymeth.2016.06.008]
42 Puleston D. Detection of Mitochondrial Mass, Damage, and Reactive Oxygen Species by Flow Cytometry. Cold Spring Harb Protoc 2015; 2015(9): pdb.prot086298-pdb.prot086298 [PMID: 26330624 DOI: 10.1101/pdb.prot086298]
43 McArthur K, Whitehead LW, Heddleston JM, Li L, Padman BS, Oorschot V, Geoghegan ND, Chappaz S, Davidson S, San Chin H, Lane RM, Dramicanin M, Saunders TL, Sugiana C, Lessene R, Osellame LD, Chew T-L, Dewson G, Lazarou M, Ramm G, Lessene G, Ryan MT, Rogers KL, van Delft MF, Kile BT. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science (New York, NY) 2018; 359(6378): eaao6047 [PMID: 29472455 DOI: 10.1126/science.aao6047]
44 Guo W, Deng L, Chen Z, Chen Z, Yu J, Liu H, Li T, Lin T, Chen H, Zhao M, Zhang L, Li G, Hu Y. Vitamin B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance. Nanomedicine (London, England) 2019; 14(3): 353-370 [PMID: 30328369 DOI: 10.2217/nnm-2018-0321]
45 Guo W, Deng L, Yu J, Chen Z, Woo Y, Liu H, Li T, Lin T, Chen H, Zhao M, Zhang L, Li G, Hu Y. Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance. Drug delivery 2018; 25(1): 1103-1116 [PMID: 29742945 PMCID: PMC6058513 DOI: 10.1080/10717544.2018.1469686]
46 Saxena S, Vekaria H, Sullivan PG, Seifert AW. Connective tissue fibroblasts from highly regenerative mammals are refractory to ROS-induced cellular senescence. Nature communications 2019; 10(1): 4400-4400 [PMID: 31562333 DOI: 10.1038/s41467-019-12398-w]
47 Li Y, Lin J, Ma J, Song L, Lin H, Tang B, Chen D, Su G, Ye S, Zhu X, Luo F, Hou Z. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy. ACS applied materials & interfaces 2017; 9(40): 34650-34665 [PMID: 28920426 DOI: 10.1021/acsami.7b10027]
48 Griffin JI, Benchimol MJ, Simberg D. Longitudinal monitoring of skin accumulation of nanocarriers and biologicals with fiber optic near infrared fluorescence spectroscopy (FONIRS). Journal of controlled release : official journal of the Controlled Release Society 2017; 247: 167-174 [PMID: 28069552 DOI: 10.1016/j.jconrel.2017.01.006]
49 Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Advanced drug delivery reviews 2011; 63(3): 131-135 [PMID: 20304019 DOI: 10.1016/j.addr.2010.03.011]
50 Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer research 2013; 73(8): 2412-2417 [PMID: 23423979 DOI: 10.1158/0008-5472.CAN-12-4561]
51 Lyu M, Zhu D, Duo Y, Li Y, Quan H. Bimetallic nanodots for tri-modal CT/MRI/PA imaging and hypoxia-resistant thermoradiotherapy in the NIR-II biological windows. Biomaterials 2020; 233: 119656-119656 [PMID: 31864762 DOI: 10.1016/j.biomaterials.2019.119656]
52 Wang Y, Zhang F, Lin H, Qu F. Biodegradable Hollow MoSe(2)/Fe(3)O(4) Nanospheres as the Photodynamic Therapy-Enhanced Agent for Multimode CT/MR/IR Imaging and Synergistic Antitumor Therapy. ACS applied materials & interfaces 2019; 11(47): 43964-43975 [PMID: 31664811 DOI: 10.1021/acsami.9b17237]
53 Majtnerova P, Rousar T. An overview of apoptosis assays detecting DNA fragmentation. Molecular biology reports 2018; 45(5): 1469-1478 [PMID: 30022463 DOI: 10.1007/s11033-018-4258-9]